Bioptik Technology Incorporation (TPEX:4161)
Taiwan
· Delayed Price · Currency is TWD 24.45
-1.00 (-3.93%)
Mar 9, 2026, 1:30 PM CST
TPEX:4161 Revenue
In the year 2025, Bioptik Technology Incorporation had annual revenue of 837.19M TWD, down -3.25%. Bioptik Technology Incorporation had revenue of 235.82M in the quarter ending December 31, 2025, with 3.51% growth.
Revenue
837.19M
Revenue Growth
-3.25%
P/S Ratio
1.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 837.19M | -28.14M | -3.25% |
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Rossmax International | 3.80B |
| Taiwan Biomaterial | 203.27M |
| AViTA | 896.85M |
| OK Biotech | 1.64B |
| Diamond Biotechnology | 698.11M |
| Wiltrom | 311.77M |
| Wellell | 2.39B |